Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Scientific Misconduct | 1 | 2013 | 21 | 0.460 |
Why?
|
| Pathology | 2 | 2016 | 101 | 0.460 |
Why?
|
| Authorship | 1 | 2013 | 53 | 0.450 |
Why?
|
| Publishing | 1 | 2013 | 220 | 0.380 |
Why?
|
| Internship and Residency | 3 | 2016 | 1375 | 0.240 |
Why?
|
| Proto-Oncogenes | 1 | 2004 | 202 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2004 | 479 | 0.210 |
Why?
|
| Trans-Activators | 2 | 2005 | 1555 | 0.200 |
Why?
|
| Transcriptional Activation | 1 | 2005 | 1070 | 0.200 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2005 | 1756 | 0.190 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2005 | 713 | 0.180 |
Why?
|
| Pathologists | 2 | 2016 | 91 | 0.170 |
Why?
|
| Breast | 1 | 2004 | 1344 | 0.150 |
Why?
|
| Biostatistics | 1 | 2016 | 20 | 0.150 |
Why?
|
| Chemistry, Clinical | 1 | 2016 | 18 | 0.140 |
Why?
|
| Flow Cytometry | 2 | 2020 | 3033 | 0.130 |
Why?
|
| DNA-Binding Proteins | 2 | 2005 | 4821 | 0.130 |
Why?
|
| Hodgkin Disease | 2 | 2019 | 1429 | 0.120 |
Why?
|
| Deception | 1 | 2013 | 19 | 0.120 |
Why?
|
| Job Application | 1 | 2013 | 19 | 0.110 |
Why?
|
| Publications | 1 | 2013 | 54 | 0.110 |
Why?
|
| Kidney Transplantation | 1 | 2019 | 755 | 0.110 |
Why?
|
| Carcinoma | 1 | 2004 | 2578 | 0.110 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 918 | 0.090 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2008 | 36 | 0.080 |
Why?
|
| RNA-Binding Protein FUS | 1 | 2008 | 26 | 0.080 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2008 | 49 | 0.080 |
Why?
|
| Immunohistochemistry | 4 | 2005 | 7548 | 0.070 |
Why?
|
| Oncogene Proteins | 1 | 2008 | 354 | 0.070 |
Why?
|
| Cyclin D | 1 | 2005 | 37 | 0.070 |
Why?
|
| Janus Kinase 1 | 1 | 2005 | 121 | 0.060 |
Why?
|
| Receptors, Growth Factor | 1 | 2004 | 157 | 0.060 |
Why?
|
| Cyclins | 1 | 2005 | 456 | 0.060 |
Why?
|
| Bone Marrow Neoplasms | 1 | 2004 | 132 | 0.060 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2008 | 755 | 0.050 |
Why?
|
| Protein Array Analysis | 1 | 2005 | 501 | 0.050 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2002 | 134 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 4654 | 0.050 |
Why?
|
| Tyrosine | 1 | 2003 | 498 | 0.050 |
Why?
|
| Aminoglycosides | 1 | 2002 | 220 | 0.050 |
Why?
|
| STAT3 Transcription Factor | 2 | 2005 | 1121 | 0.050 |
Why?
|
| Carcinoma in Situ | 1 | 2004 | 487 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2005 | 4804 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2004 | 15694 | 0.040 |
Why?
|
| Immunophenotyping | 2 | 2020 | 1681 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2004 | 1234 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2002 | 943 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2002 | 1385 | 0.040 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2004 | 1216 | 0.040 |
Why?
|
| Humans | 11 | 2020 | 261506 | 0.040 |
Why?
|
| Comprehension | 1 | 2016 | 120 | 0.030 |
Why?
|
| United States | 1 | 2013 | 15433 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2016 | 5687 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2004 | 6150 | 0.030 |
Why?
|
| Leukemia | 1 | 2002 | 1635 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2005 | 14551 | 0.030 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2003 | 1664 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2005 | 29902 | 0.020 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2003 | 2390 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2003 | 3552 | 0.020 |
Why?
|
| Education, Medical, Graduate | 1 | 2016 | 671 | 0.020 |
Why?
|
| Aged | 4 | 2019 | 70117 | 0.020 |
Why?
|
| Transcriptional Regulator ERG | 1 | 2008 | 61 | 0.020 |
Why?
|
| Interleukin-3 | 1 | 2008 | 96 | 0.020 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2008 | 71 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2004 | 8873 | 0.020 |
Why?
|
| CDC2 Protein Kinase | 1 | 2008 | 176 | 0.020 |
Why?
|
| Middle Aged | 5 | 2005 | 86204 | 0.020 |
Why?
|
| Female | 4 | 2005 | 141928 | 0.020 |
Why?
|
| Adult | 4 | 2005 | 77950 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2005 | 10331 | 0.020 |
Why?
|
| Male | 4 | 2019 | 123000 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2008 | 442 | 0.020 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2008 | 749 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 1487 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 448 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2003 | 6009 | 0.010 |
Why?
|
| Sialic Acid Binding Ig-like Lectin 3 | 1 | 2002 | 83 | 0.010 |
Why?
|
| Immunotoxins | 1 | 2002 | 117 | 0.010 |
Why?
|
| Azacitidine | 1 | 2008 | 1149 | 0.010 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2008 | 1299 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2002 | 409 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2003 | 652 | 0.010 |
Why?
|
| Survival Analysis | 2 | 2003 | 9180 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2008 | 1399 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2003 | 1620 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2003 | 3536 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2008 | 4078 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 2508 | 0.010 |
Why?
|
| Protein Binding | 1 | 2003 | 3438 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 4298 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2008 | 5270 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2003 | 32848 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2003 | 10001 | 0.010 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2002 | 3251 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2002 | 2992 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2002 | 4367 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 12926 | 0.010 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2002 | 2979 | 0.010 |
Why?
|
| Survival Rate | 1 | 2002 | 12221 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2004 | 14889 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2002 | 12873 | 0.000 |
Why?
|
| Mice | 1 | 2008 | 34495 | 0.000 |
Why?
|
| Prognosis | 1 | 2003 | 21713 | 0.000 |
Why?
|
| Animals | 1 | 2008 | 59536 | 0.000 |
Why?
|
| Adolescent | 1 | 2003 | 31252 | 0.000 |
Why?
|
| Child | 1 | 2003 | 29154 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2002 | 14289 | 0.000 |
Why?
|